A new analysis from the AARP Public Policy Institute finds drug companies have increased prices for many brand name Part D drugs in 2022, contributing to affordability challenges for people with Medicare. According to the report, 75 of the 100 brand name drugs with the highest Medicare Part D spending in 2020 saw their list … Continue reading Drug Prices Already Rising in 2022